Ani Pharmaceuticals (ANIP) EV to CFO (2013 - 2026)
Ani Pharmaceuticals' (ANIP) EV to CFO came in at 8.52 for Q2 2026, down 4.3% from 8.90 a year earlier but up 17.3% from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) EV to CFO (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EV to CFO at Ani Pharmaceuticals was 3.98, down 30.6% year-over-year; for FY2025, it was 8.04, down 49.6% from FY2024.
- In prior years, Ani Pharmaceuticals' EV to CFO was 15.96 in FY2024 (+106.0%), 7.75 in FY2023 and 144.53 in FY2021 (+528.8%).
- Quarterly EV to CFO has run from a low of 7.27 in Q1 2026 to a high of 144.53 in Q4 2021 over five years.
- On a year-over-year basis, EV to CFO has declined in each of the last five quarters, with growth averaging 1.5% over the last eight quarters.
- The strongest year-over-year quarter for EV to CFO in the past five years was Q4 2021, with growth of 528.8%; the weakest was Q1 2024, with a decline of 84.7%.
- According to Business Quant data, EV to CFO for the three prior quarters was 7.27 (Q1 2026), 8.04 (Q4 2025) and 10.84 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Ani Pharmaceuticals | 1.43 Bn | 212.92 Mn | 165.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.52 |
| Mar 31, 2026 | 7.27 |
| Dec 31, 2025 | 8.04 |
| Sep 30, 2025 | 10.84 |
| Jun 30, 2025 | 8.90 |
| Mar 31, 2025 | 16.60 |
| Dec 31, 2024 | 15.96 |
| Sep 30, 2024 | 12.24 |
| Jun 30, 2024 | 10.01 |
| Mar 31, 2024 | 10.78 |
| Dec 31, 2023 | 7.75 |
| Sep 30, 2023 | 14.41 |
| Jun 30, 2023 | 22.56 |
| Mar 31, 2023 | 70.63 |
| Dec 31, 2021 | 144.53 |
| Sep 30, 2021 | 41.12 |
| Jun 30, 2021 | 31.10 |
| Mar 31, 2021 | 12.72 |
| Dec 31, 2020 | 22.98 |
| Sep 30, 2020 | 12.82 |
API Access
Ani Pharmaceuticals EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();